Sanofi: all 2,424 studies
Page 15 of 25. Open to participants first (105), then studies with results posted, then the rest; newest registration first within each.
- Safety, Tolerability and Pharmacokinetics of SAR113945 in Japanese Patients With Knee OsteoarthritisCompletedNCT01511549Phase 1
- Cabazitaxel in Asian Patients With Advanced Gastric Cancer Who Failed Prior ChemotherapyCompletedNCT01497964Phase 1/2
- Single Dose Study With a New Insulin Glargine Formulation and Lantus® in Japanese Patients With Type 1 Diabetes MellitusCompletedNCT01493115Phase 1
- Safety of PENTAXIM® Given as a Three-Dose Primary Vaccination at 2, 3, and 4 Months of Age in Infants in ChinaCompletedNCT01491087Phase 4
- KD019 Versus Erlotinib in Subjects With Stage IIIB/IV Non Small Cell Lung Cancer With Progression After First- or Second-Line ChemotherapyTerminatedNCT01487174Phase 3
- Safety and Efficacy of Teriflunomide (HMR1726) in Multiple Sclerosis With RelapsesCompletedNCT01487096Phase 2
- Repeated Dosing Study to Assess Safety and Tolerability in CKD-3 Patients on Stable ACE-I TreatmentCompletedNCT01485900Phase 1
- Single and Repeated Dosing Study to Assess the Safety and the Concentration-time Profile of SAR228810 in Alzheimer's PatientsCompletedNCT01485302Phase 1
- ALX-0171 Phase I Study, Evaluating Single Ascending Dose and Multiple Dose in Healthy Male VolunteersCompletedNCT01483911Phase 1
- Study of a Quadrivalent Influenza Vaccine Administered Intramuscularly in Children/Adolescents and AdultsCompletedNCT01481454Phase 3
- Prospective Dengue Seroprevalence Study in 5 to 10 Year-old ChildrenCompletedNCT01477671
- Sequential Inactivated Poliomyelitis Vaccine Followed by Oral Poliomyelitis Vaccine Versus Oral Poliomyelitis VaccineCompletedNCT01475539Phase 4
- SAR3419 as Single Agent in Relapsed-Refractory Diffuse Large B-Cell Lymphoma (DLBCL) PatientsCompletedNCT01472887Phase 2
- Combination of SAR3419 and Rituximab in Relapsed/Refractory Diffuse Large B-Cell LymphomaCompletedNCT01470456Phase 2
- Safety of Single Doses of SAR113945 and Efficacy and Safety of a New Formulation Given Into the Knee in Osteoarthritis Patients / Part ICompletedNCT01463488Phase 1
- Efficacy and Safety of SAR292833 Administration for 4 Weeks in Patients With Chronic Peripheral Neuropathic PainCompletedNCT01463397Phase 2
- Effectiveness and Safety of Treatment of Insulin Glargine in Type 2 Diabetes Mellitus Following Glucagon-like Peptide-1 (GLP-1) FailureCompletedNCT01461577Phase 4
- Efficacy and Safety Comparison of Metformin/Glimepiride Combination Versus Each Compound Alone in New Diagnosed Type 2 Diabetes PatientsCompletedNCT01459809Phase 3
- Evaluation of Fixed Dose Combination of Glimepiride and Metformin in Chinese Type 2 Diabetes Patients Inadequately Controlled With MetforminCompletedNCT01457911Phase 3
- A Dose Escalation Study of Iniparib as a Single Agent and in Combination in Solid TumorsCompletedNCT01455532Phase 1
- A Phase I Study of the Pharmacokinetic Variability and Relative Bioavailability of the Phase 3 and Common Blend Formulations of Eliglustat in Healthy Adult SubjectsCompletedNCT01452542Phase 1
- Ascending Dose Study of the Safety and Tolerability of Alirocumab (SAR236553/REGN727) in Japanese Healthy VolunteersCompletedNCT01448317Phase 1
- Study of the Tolerability, Safety, Pharmacokinetics and Pharmacodynamics of Alirocumab SAR236553 (REGN727)CompletedNCT01448304Phase 1
- Injection Site Tolerability, Safety, Pharmacokinetics and Pharmacodynamics Study After a Single Dose Subcutaneous Treatment of Alirocumab SAR236553 (REGN727)CompletedNCT01448239Phase 1
- Study of Investigational Pneumococcal Vaccine in Healthy Adults, Toddlers and InfantsCompletedNCT01446926Phase 1
- Anti-parasitic Activity and Safety Assessment of SAR97276A in Children With Uncomplicated MalariaTerminatedNCT01445938Phase 2
- Study of an Investigational Pneumococcal Vaccine at Three Dose Levels in Healthy AdultsCompletedNCT01444352Phase 1
- Study of Two Investigational Pneumococcal Vaccines in Healthy AdultsCompletedNCT01444339Phase 1
- Study of an Investigational Pneumococcal Vaccine in Healthy Adult VolunteersCompletedNCT01444001Phase 1
- Injection Site Tolerability, Safety, Pharmacokinetics, Pharmacodynamics in Different Single-Dose Treatments of Alirocumab SAR236553 (REGN727) in Healthy SubjectsCompletedNCT01443650Phase 1
- SAR3419 in Acute Lymphoblastic LeukemiaTerminatedNCT01440179Phase 2
- A Clinical Trial to Assess the Clinical Benefit of SSR411298 as Adjunctive Treatment for Persistent Cancer PainTerminatedNCT01439919Phase 2
- A Study of Investigational SAR256212 in Combination With SAR245408 in Patients With Solid Tumor CancersCompletedNCT01436565Phase 1
- Ibuprofen Versus Ibuprofen Plus Caffeine in the Treatment of Migraine.WithdrawnNCT01426971Phase 3
- Study Combining SAR245409 With Rituximab or Bendamustine Plus Rituximab in Patients With Indolent Lymphoma, Mantle Cell Lymphoma and Chronic Lymphocytic LeukemiaCompletedNCT01410513Phase 1
- A Study of Investigational SAR245409 in Patients With Certain Lymphoma or LeukemiaCompletedNCT01403636Phase 2
- Study Comparing The Tolerability Of Three Excipient Formulations Administered Subcutaneously To Healthy SubjectsCompletedNCT01401764Phase 1
- Safety and Pharmacokinetics of SAR245408 Daily Oral in Patients With Solid TumorsCompletedNCT01392924Phase 1
- Study of SAR125844 Single Agent Administered as Slow Intravenous Infusion in Adult Patients With Advanced Malignant Solid TumorsCompletedNCT01391533Phase 1
- Pharmacokinetics, Pharmacodynamics and Safety Evaluation of SAR279356 in Intensive Care Unit Mechanically Ventilated PatientsTerminatedNCT01389700Phase 2
- Study of SP059 Given Subcutaneously as a Three-dose Primary and Booster Vaccination in Infants in JapanCompletedNCT01389687Phase 3
- Efficacy and Tolerability of Artesunate Amodiaquine Versus Chloroquine in the Treatment of Uncomplicated Plasmodium Vivax MalariaCompletedNCT01378286Phase 3
- First in Man Study of ALX-0651, a Nanobody Inhibiting CXCR4TerminatedNCT01374503Phase 1
- Analysis of Data Collected in the European Group for Blood and Marrow Transplantation (EBMT) Registry for Off-Label Transplant Use of PlerixaforCompletedNCT01362985
- Analysis of Data Collected in the European Group for Blood and Marrow Transplantation (EBMT) Registry on a Cohort of Patients Receiving PlerixaforCompletedNCT01362972
- A Phase 1 Study Evaluating Eliglustat's Effects on Pharmacokinetics, Safety & Tolerability of Digoxin in Healthy AdultsCompletedNCT01357811Phase 1
- Oral SAR245408 (XL147) and Oral MSC1936369B in Patients With Locally Advanced or Metastatic Solid TumorsCompletedNCT01357330Phase 1
- Assessment of Efficacy and Safety of Insuman Comb 25 Versus Novolin® 30R Twice Daily Over 24 Weeks in Type 2 Diabetes Patients With Insulin TherapyCompletedNCT01353469Phase 3
- Repeated Dosing Study With a New Insulin Glargine Formulation and Lantus® in Patients With Type 1 Diabetes MellitusCompletedNCT01349855Phase 1
- Study of the Purified Vero Rabies Vaccine - Serum Free in Comparison With the Reference Purified Vero Rabies VaccineCompletedNCT01339312Phase 3
- Lantus Versus Humalog Mix as add-on Therapy in Type Diabetes Patients Failing Sulfonylurea and Metformin Combination TreatmentCompletedNCT01336751Phase 3
- Study of Ombrabulin in Patients With Platinum-Sensitive Recurrent Ovarian Cancer Treated With Carboplatin/PaclitaxelCompletedNCT01332656Phase 2
- Comparison of the Safety and Pharmacokinetics of Two SAR153191 (REGN88) Drug Products in Rheumatoid Arthritis PatientsCompletedNCT01328522Phase 1
- Dose Escalation Study With Cabazitaxel in Combination With Daily Prednisolone in Patients With Hormone Refractory Prostate CancerCompletedNCT01324583Phase 1
- Fexofenadine HCL - Pseudoephedrine HCL Combination Versus Allegra in Patients With Seasonal Allergic RhinitisCompletedNCT01306721Phase 3
- A Dose-escalation Study of Ombrabulin in Combination With Paclitaxel and Carboplatin in Patients With Advanced Solid TumorsCompletedNCT01293630Phase 1
- Study of Febrile Illness for Dengue-Endemic Areas in Latin AmericaCompletedNCT01293331
- A Combined Study in Pediatric Cancer Patients for Dose Ranging and Efficacy/Safety of Plerixafor Plus Standard Regimens for Mobilization Versus Standard Regimens AloneCompletedNCT01288573Phase 1/2
- Safety and Immunogenicity Study of a Diphtheria, Tetanus, Acellular Pertussis and Poliomyelitis Vaccine (REPEVAX) Followed by 2 Doses of a Diphtheria, Tetanus and Poliomyelitis Vaccine (REVAXIS) in Subjects of 40 Years of Age or OlderCompletedNCT01287949Phase 3
- Study to Assess Safety and Efficacy of Anti-Interleukin 6-receptor (IL6R) Nanobody in Rheumatoid Arthritis (RA) PatientsCompletedNCT01284569Phase 1/2
- A Single Dose Study Of The Safety And Investigational Product Level Measurement In Healthy SubjectsCompletedNCT01284036Phase 1
- Long-Term Study on Safety and Immunogenicity of HEPLISAV™ and Engerix-B® in Adults With Chronic Kidney DiseaseCompletedNCT01282762
- A Safety Study of IMOVAX Polio Vaccine in Selected Cities in ChinaCompletedNCT01278433Phase 4
- Effect of Different Doses of SAR110894 on Cognition in Patients With Mild to Moderate Alzheimer's Disease on DonepezilCompletedNCT01266525Phase 2
- Concurrent Chemoradiotherapy Using Intensity Modulated Radiotherapy (IMRT) & Docetaxel-cisplatin (or Carboplatin) Followed by Adjuvant Chemotherapy for Inoperable Stage III Non-small-cell Lung CancerCompletedNCT01266512Phase 2
- Trial of Ombrabulin (AVE8062) in Combination With Taxane and Platinum in Patients With Non-small Cell Lung CancerCompletedNCT01263886Phase 2
- Early Access to Cabazitaxel in Patients With Metastatic Hormone Refractory Prostate Cancer Previously Treated With a Docetaxel-containing RegimenCompletedNCT01254279Phase 3
- Safety and Immunogenicity Study of Concomitant Versus Non Concomitant Administration of a Diphtheria, Tetanus, Pertussis and Poliomyelitis Vaccine (REPEVAX) and Influenza Vaccine (VAXIGRIP) in Subjects Aged From 60 Years OldCompletedNCT01249183Phase 3
- Oxaliplatin and Capecitabine on Top of Sorafenib Versus Sorafenib Alone in Advanced Hepatocellular Carcinoma PatientsWithdrawnNCT01245582Phase 3
- A Study of the Safety of IMOVAX Polio™ in ChinaCompletedNCT01244464Phase 4
- Safety, Efficacy and Pharmacokinetic Study of Allegra in Pediatric Patients With Atopic Dermatitis (AD)CompletedNCT01244230Phase 2/3
- Safety, Efficacy and Pharmacokinetic Study of Allegra in Pediatric Patients With Perennial Allergic Rhinitis (PAR)CompletedNCT01244217Phase 2/3
- Exploratory Study of XL765 (SAR245409) or XL147 (SAR245408) in Subjects With Recurrent Glioblastoma Who Are Candidates for Surgical ResectionCompletedNCT01240460Phase 1
- Pharmacokinetic and Tolerability Study of 14 mg Single Dose of Teriflunomide in Subjects With Severe Renal ImpairmentCompletedNCT01239459Phase 1
- Evaluation of the Prandial Treatment Adjustment Effect Via Continuous Glucose Monitoring on Type 2 Diabetes Mellitus (DM) Patients Uncontrolled With a Basal Insulin or Premix Once a DayCompletedNCT01234597Phase 4
- Study of AVE1642 Anti-IGF1R Monoclonal Antibody in Patients With Advanced Multiple MyelomaCompletedNCT01233895Phase 1
- Study of Different Formulations of a Clostridium Difficile Toxoid Vaccine Given at Three Different Schedules in AdultsCompletedNCT01230957Phase 2
- Efficacy and Safety of Insulin Glargine Versus. Neutral Protamine Hagedorn (NPH) Insulin in Children With Type 1 Diabetes Above 6 Years Old.CompletedNCT01223131Phase 3
- Prospective Surveillance of Febrile Illness for Dengue-Endemic Areas in AsiaCompletedNCT01218906
- Study of Sanofi Pasteur's Intradermal Influenza Vaccine (IDflu™) in Adults and Elderly in KoreaCompletedNCT01215669Phase 4
- Study of PENTAXIM™ Vaccine Versus TETRAXIM™ Vaccine Given With ACTHIB™ Vaccine in South Korean Infants.CompletedNCT01214889Phase 3
- Safety and Pharmacokinetics of SAR240550 (BSI-201) Twice Weekly in Patients With Advanced Solid TumorsCompletedNCT01213381Phase 1
- Dose Ranging Study of Dronedarone for the Control of Ventricular Rate in Japanese Patients With Permanent Atrial FibrillationCompletedNCT01213368Phase 2
- Comparison of Insulin Glargine/Insulin Glulisine Regimen to Insulin Aspart/Insulin Aspart Protamine 30/70 in Type 2 Diabetes Mellitus Patients (T2DM)CompletedNCT01212913Phase 4
- baSal BoluS Therapy in patIenTs With TypE 1 Diabetes MellitusCompletedNCT01204593Phase 4
- ADIponectin and Asymmetric Dimethylarginine (ADMA) Level in Type-2 Diabetes Patients After 12 Weeks of Treatment With GlimepiRide And Metformin Fixed Dose CombinationCompletedNCT01204580Phase 4
- Two Regimens of SAR240550/Weekly Paclitaxel and Paclitaxel Alone as Neoadjuvant Therapy in Triple Negative Breast Cancer PatientsCompletedNCT01204125Phase 2
- Intensive Insulin Glulisine Therapy in Patients With Type 2 Diabetes Inadequately Controlled With Basal Insulin and Oral Glucose-lowering DrugsCompletedNCT01203111Phase 4
- Apidra Children & Adolescents StudyCompletedNCT01202474Phase 4
- Pharmacokinetics and Optimal Timing of Dronedarone Initiation Following Long-term Amiodarone in Patients With Paroxysmal or Persistent Atrial FibrillationCompletedNCT01199081Phase 4
- A Study of Clofarabine in Japanese Paediatric Patients With Relapsed or Refractory Acute Lymphoblastic LeukaemiaCompletedNCT01196013Phase 1
- Euglycemic Clamp Dose-response Study Comparing a New Insulin Glargine Formulation With Lantus®CompletedNCT01195454Phase 1
- Safety and Immunogenicity of HEPLISAV™ a Hepatitis B Virus Vaccine in Adults on HemodialysisCompletedNCT01195246Phase 3
- Benefit/Risk Evaluation of Insuman Implantable Versus Insuplant Using Medtronic MiniMed Implantable Pump System in Patients With Type 1 DiabetesCompletedNCT01194882Phase 3
- Dose-escalation, Safety, Pharmacokinetics Study of AVE8062 Combined With Bevacizumab in Patients With Advanced Solid TumorsCompletedNCT01193595Phase 1
- A Study Evaluating INIPARIB in Combination With Chemotherapy to Treat Triple Negative Breast Cancer Brain MetastasisCompletedNCT01173497Phase 2
- Evaluation of the Effectiveness and Safety of Physician Versus Patient-led of Insulin Glargine Initiation and Titration in Type 2 Diabetes MellitusCompletedNCT01169818Phase 4
- An Open-label Study Investigating the Disposition and QT/QTc Interval Effects of 400 mg [14C]-Iniparib(3.7 MBq, 100 µCi)CompletedNCT01161836Phase 1
- Pharmacodynamic and Pharmacokinetic Effects of Insulin Glulisine in Obese Subjects With Type 2 Diabetes After a Standard Meal in Comparison to Insulin AspartCompletedNCT01159353Phase 1
- Dermacyd in Odor Reducing.CompletedNCT01158365Phase 3